Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Neuropsychopharmacology (18)
Translational Psychiatry (4)
Scientific Reports (3)
Nature Communications (2)
Molecular Psychiatry (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (28)
Correspondence (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biomarkers
Biophysics
Chemical biology
Diseases
Drug discovery
Environmental sciences
Environmental social sciences
Genetics
Health care
Immunology
Medical research
Microbiology
Neuroscience
Physiology
Psychology
Structural biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–30 of 30 results

Advanced filters: Author: Matthias E Liechti Clear advanced filters

Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT₂ Antagonist Ketanserin in Healthy Humans

Matthias E Liechti
Matthias R Saur
Franz X Vollenweider
Research01 Oct 2000
Neuropsychopharmacology

Volume: 23, P: 396-404
Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants

Isabelle Straumann
Patrick Vizeli
Matthias E. Liechti
ResearchOpen Access25 Sept 2025
Neuropsychopharmacology

P: 1-10
The Metabotropic Glutamate 2/3 Receptor Agonist LY379268 Blocked Nicotine-Induced Increases in Nucleus Accumbens Shell Dopamine only in the Presence of a Nicotine-Associated Context in Rats

Manoranjan S D'Souza
Matthias E Liechti
Athina Markou
Research08 Jun 2011
Neuropsychopharmacology

Volume: 36, P: 2111-2124
Modern Clinical Research on LSD

Matthias E Liechti
ReviewsOpen Access27 Apr 2017
Neuropsychopharmacology

Volume: 42, P: 2114-2127
Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin

Matthias E Liechti
Mark A Geyer
Franz X Vollenweider
Research01 Mar 2001
Neuropsychopharmacology

Volume: 24, P: 240-252
Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram

Matthias E Liechti
Christine Baumann
Franz X Vollenweider
Research01 May 2000
Neuropsychopharmacology

Volume: 22, P: 513-521
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants

Livio Erne
Severin B. Vogt
Matthias E. Liechti
ResearchOpen Access19 Dec 2024
Neuropsychopharmacology

Volume: 50, P: 1008-1016
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses

Similarity of antibody responses in HIV-1 transmission pairs reveals a significant impact of the virus genome on imprinting antibody responses.

Roger D. Kouyos
Peter Rusert
Sabine Yerly
Research10 Sept 2018
Nature

Volume: 561, P: 406-410
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization

The V3-crown of the HIV-1 envelope protein largely elicits non-neutralizing antibodies. Here, the authors show that the V3-crown can be targeted by broadly neutralizing designed ankyrin repeat proteins recognizing two conformations one of which resembles CCR5- bound V3.

Nikolas Friedrich
Emanuel Stiegeler
Alexandra Trkola
ResearchOpen Access18 Nov 2021
Nature Communications

Volume: 12, P: 1-18
Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects

Aaron Klaiber
Yasmin Schmid
Matthias E. Liechti
ResearchOpen Access30 Sept 2024
Translational Psychiatry

Volume: 14, P: 1-8
Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants

Patrick Vizeli
Erich Studerus
Matthias E. Liechti
ResearchOpen Access04 Sept 2024
Translational Psychiatry

Volume: 14, P: 1-8
Crystal structure of the α_1B-adrenergic receptor reveals molecular determinants of selective ligand recognition

This study reports the X-ray structure of the α_1B-adrenergic G protein-coupled receptor bound to an inverse agonist, and unveils key determinants of subtype-selective ligand binding that may help the design of aminergic drugs with fewer side-effects.

Mattia Deluigi
Lena Morstein
Andreas Plückthun
ResearchOpen Access19 Jan 2022
Nature Communications

Volume: 13, P: 1-13
Nanopore sequencing improves the draft genome of the human pathogenic amoeba Naegleria fowleri

Nicole Liechti
Nadia Schürch
Matthias Wittwer
ResearchOpen Access05 Nov 2019
Scientific Reports

Volume: 9, P: 1-10
Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants

Isabelle Straumann
Isidora Avedisian
Matthias E. Liechti
ResearchOpen Access23 Aug 2024
Neuropsychopharmacology

Volume: 50, P: 362-371
Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants

Isabelle Straumann
Laura Ley
Matthias E. Liechti
ResearchOpen Access31 May 2023
Neuropsychopharmacology

Volume: 48, P: 1840-1848
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants

Severin B. Vogt
Laura Ley
Matthias E. Liechti
ResearchOpen Access23 May 2023
Translational Psychiatry

Volume: 13, P: 1-9
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

Laura Ley
Friederike Holze
Matthias E. Liechti
ResearchOpen Access25 May 2023
Neuropsychopharmacology

Volume: 48, P: 1659-1667
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Friederike Holze
Patrick Vizeli
Matthias E. Liechti
ResearchOpen Access16 Nov 2019
Neuropsychopharmacology

Volume: 45, P: 462-471
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

Friederike Holze
Laura Ley
Matthias E. Liechti
ResearchOpen Access25 Feb 2022
Neuropsychopharmacology

Volume: 47, P: 1180-1187
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Friederike Holze
Patrick Vizeli
Matthias E. Liechti
ResearchOpen Access15 Oct 2020
Neuropsychopharmacology

Volume: 46, P: 537-544
Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis

Patrick Vizeli
Isabelle Straumann
Matthias E. Liechti
ResearchOpen Access25 May 2021
Scientific Reports

Volume: 11, P: 1-9
Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine

Mihai Avram
Lydia Fortea
Stefan Borgwardt
ResearchOpen Access11 Sept 2024
Molecular Psychiatry

Volume: 30, P: 1297-1307
Inter-individual variability in neural response to low doses of LSD

Nadia R. P. W. Hutten
Conny W. E. M. Quaedflieg
Johannes G. Ramaekers
ResearchOpen Access15 Jul 2024
Translational Psychiatry

Volume: 14, P: 1-10
The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Peter Bedford
Daniel J. Hauke
Andreea O. Diaconescu
ResearchOpen Access25 Apr 2023
Neuropsychopharmacology

Volume: 48, P: 1175-1183
MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens

Felix Müller
Friederike Holze
Stefan Borgwardt
ResearchOpen Access20 Nov 2020
Neuropsychopharmacology

Volume: 46, P: 545-553
Draft Genome Sequence of Chromatium okenii Isolated from the Stratified Alpine Lake Cadagno

Samuel M. Luedin
Nicole Liechti
Mauro Tonolla
ResearchOpen Access13 Feb 2019
Scientific Reports

Volume: 9, P: 1-14
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality

Patrick C Dolder
Yasmin Schmid
Matthias E Liechti
ResearchOpen Access01 Jun 2016
Neuropsychopharmacology

Volume: 41, P: 2638-2646
High-resolution land use/cover forecasts for Switzerland in the 21st century

Luca Bütikofer
Antoine Adde
Christophe Randin
ResearchOpen Access23 Feb 2024
Scientific Data

Volume: 11, P: 1-10
Is A Single Dose of MDMA Harmless

Franz X Vollenweider
Alex Gamma
Theo Huber
Correspondence01 Oct 1999
Neuropsychopharmacology

Volume: 21, P: 598-600
Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

Franz X Vollenweider
Alex Gamma
Theo Huber
Research01 Oct 1998
Neuropsychopharmacology

Volume: 19, P: 241-251

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT₂ Antagonist Ketanserin in Healthy Humans

Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants

The Metabotropic Glutamate 2/3 Receptor Agonist LY379268 Blocked Nicotine-Induced Increases in Nucleus Accumbens Shell Dopamine only in the Presence of a Nicotine-Associated Context in Rats

Modern Clinical Research on LSD

Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin

Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram

Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants

Tracing HIV-1 strains that imprint broadly neutralizing antibody responses

Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization

Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects

Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants

Crystal structure of the α_1B-adrenergic receptor reveals molecular determinants of selective ligand recognition

Nanopore sequencing improves the draft genome of the human pathogenic amoeba Naegleria fowleri

Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine

Inter-individual variability in neural response to low doses of LSD

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens

Draft Genome Sequence of Chromatium okenii Isolated from the Stratified Alpine Lake Cadagno

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality

High-resolution land use/cover forecasts for Switzerland in the 21st century

Is A Single Dose of MDMA Harmless

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

Search

Quick links